| NGF; nerve growth factor (beta polypeptide) [KO: K02582] |
| BDNF; brain-derived neurotrophic factor [KO: K04355] |
| NTF4; neurotrophin 4 [KO: K12457] |
| NTF3; neurotrophin 3 [KO: K04356] |
| NTRK1; neurotrophic tyrosine kinase, receptor, type 1 [KO: K03176] [EC: 2.7.10.1] |
| NTRK2; neurotrophic tyrosine kinase, receptor, type 2 [KO: K04360] [EC: 2.7.10.1] |
| NTRK3; neurotrophic tyrosine kinase, receptor, type 3 [KO: K05101] [EC: 2.7.10.1] |
| SH2B2; SH2B adaptor protein 2 [KO: K07193] |
| SH2B1; SH2B adaptor protein 1 [KO: K12459] |
| SH2B3; SH2B adaptor protein 3 [KO: K12459] |
| GRB2; growth factor receptor-bound protein 2 [KO: K04364] |
| SOS1; son of sevenless homolog 1 (Drosophila) [KO: K03099] |
| SOS2; son of sevenless homolog 2 (Drosophila) [KO: K03099] |
| HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog [KO: K02833] |
| KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO: K07827] |
| NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO: K07828] |
| RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO: K04366] [EC: 2.7.11.1] |
| BRAF; v-raf murine sarcoma viral oncogene homolog B1 [KO: K04365] [EC: 2.7.11.1] |
| MAP2K1; mitogen-activated protein kinase kinase 1 [KO: K04368] [EC: 2.7.12.2] |
| MAP2K2; mitogen-activated protein kinase kinase 2 [KO: K04369] [EC: 2.7.12.2] |
| |
| |
| RPS6KA3; ribosomal protein S6 kinase, 90kDa, polypeptide 3 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA1; ribosomal protein S6 kinase, 90kDa, polypeptide 1 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA2; ribosomal protein S6 kinase, 90kDa, polypeptide 2 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA6; ribosomal protein S6 kinase, 90kDa, polypeptide 6 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5 [KO: K04445] [EC: 2.7.11.1] |
| ATF4; activating transcription factor 4 (tax-responsive enhancer element B67) [KO: K04374] |
| BCL2; B-cell CLL/lymphoma 2 [KO: K02161] |
| KIDINS220; kinase D-interacting substrate, 220kDa [KO: K12460] |
| FRS2; fibroblast growth factor receptor substrate 2 [KO: K12461] |
| CRK; v-crk sarcoma virus CT10 oncogene homolog (avian) [KO: K04438] |
| CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like [KO: K04438] |
| RAPGEF1; Rap guanine nucleotide exchange factor (GEF) 1 [KO: K06277] |
| RAP1A; RAP1A, member of RAS oncogene family [KO: K04353] |
| RAP1B; RAP1B, member of RAS oncogene family [KO: K07836] |
| MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO: K04421] [EC: 2.7.11.25] |
| MAP2K5; mitogen-activated protein kinase kinase 5 [KO: K04463] [EC: 2.7.12.2] |
| |
| |
| |
| |
| |
| MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [KO: K04443] [EC: 2.7.11.1] |
| SHC2; SHC (Src homology 2 domain containing) transforming protein 2 [KO: K06279] |
| SHC4; SHC (Src homology 2 domain containing) family, member 4 [KO: K06279] |
| SHC3; SHC (Src homology 2 domain containing) transforming protein 3 [KO: K06279] |
| SHC1; SHC (Src homology 2 domain containing) transforming protein 1 [KO: K06279] |
| GAB1; GRB2-associated binding protein 1 [KO: K09593] |
| PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [KO: K02649] |
| PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5 [KO: K02649] |
| PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta) [KO: K02649] |
| PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma) [KO: K02649] |
| PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha [KO: K00922] [EC: 2.7.1.153] |
| PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta [KO: K00922] [EC: 2.7.1.153] |
| PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma [KO: K00922] [EC: 2.7.1.153] |
| AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO: K04456] [EC: 2.7.11.1] |
| AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO: K04456] [EC: 2.7.11.1] |
| AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO: K04456] [EC: 2.7.11.1] |
| NFKBIB; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta [KO: K02581] |
| NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [KO: K04734] |
| NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon [KO: K05872] |
| NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO: K02580] |
| RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO: K04735] |
| FOXO3; forkhead box O3 [KO: K09408] |
| FASLG; Fas ligand (TNF superfamily, member 6) [KO: K04389] |
| BAD; BCL2-associated agonist of cell death [KO: K02158] |
| |
| PDK1; pyruvate dehydrogenase kinase, isozyme 1 [KO: K12077] [EC: 2.7.11.2] |
| IRS1; insulin receptor substrate 1 [KO: K16172] |
| |
| PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific) [KO: K05859] [EC: 3.1.4.11] |
| CALML3; calmodulin-like 3 [KO: K02183] |
| CALM2; calmodulin 2 (phosphorylase kinase, delta) [KO: K02183] |
| CALM3; calmodulin 3 (phosphorylase kinase, delta) [KO: K02183] |
| CALM1; calmodulin 1 (phosphorylase kinase, delta) [KO: K02183] |
| CALML6; calmodulin-like 6 [KO: K02183] |
| CALML5; calmodulin-like 5 [KO: K02183] |
| CAMK2A; calcium/calmodulin-dependent protein kinase II alpha [KO: K04515] [EC: 2.7.11.17] |
| CAMK2D; calcium/calmodulin-dependent protein kinase II delta [KO: K04515] [EC: 2.7.11.17] |
| CAMK2B; calcium/calmodulin-dependent protein kinase II beta [KO: K04515] [EC: 2.7.11.17] |
| CAMK2G; calcium/calmodulin-dependent protein kinase II gamma [KO: K04515] [EC: 2.7.11.17] |
| CAMK4; calcium/calmodulin-dependent protein kinase IV [KO: K05869] [EC: 2.7.11.17] |
| ABL1; c-abl oncogene 1, non-receptor tyrosine kinase [KO: K06619] [EC: 2.7.10.2] |
| PTPN11; protein tyrosine phosphatase, non-receptor type 11 [KO: K07293] [EC: 3.1.3.48] |
| MATK; megakaryocyte-associated tyrosine kinase [KO: K08888] [EC: 2.7.10.2] |
| NGFR; nerve growth factor receptor [KO: K02583] |
| ARHGDIB; Rho GDP dissociation inhibitor (GDI) beta [KO: K12462] |
| ARHGDIA; Rho GDP dissociation inhibitor (GDI) alpha [KO: K12462] |
| ARHGDIG; Rho GDP dissociation inhibitor (GDI) gamma [KO: K12462] |
| RHOA; ras homolog family member A [KO: K04513] |
| CDC42; cell division cycle 42 [KO: K04393] |
| RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO: K04392] |
| MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase [KO: K04416] [EC: 2.7.11.25] |
| MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO: K04426] [EC: 2.7.11.25] |
| MAP2K7; mitogen-activated protein kinase kinase 7 [KO: K04431] [EC: 2.7.12.2] |
| |
| |
| |
| JUN; jun proto-oncogene [KO: K04448] |
| TP53; tumor protein p53 [KO: K04451] |
| BAX; BCL2-associated X protein [KO: K02159] |
| TP73; tumor protein p73 [KO: K10148] |
| TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase [KO: K03175] |
| ZNF274; zinc finger protein 274 [KO: K12458] |
| PRDM4; PR domain containing 4 [KO: K12463] |
| MAGED1; melanoma antigen family D, 1 [KO: K12464] |
| NGFRAP1; nerve growth factor receptor (TNFRSF16) associated protein 1 [KO: K12465] |
| YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide [KO: K06630] |
| RIPK2; receptor-interacting serine-threonine kinase 2 [KO: K08846] [EC: 2.7.11.1] |
| IRAK1; interleukin-1 receptor-associated kinase 1 [KO: K04730] [EC: 2.7.11.1] |
| IRAK2; interleukin-1 receptor-associated kinase 2 [KO: K04731] [EC: 2.7.11.1] |
| IRAK3; interleukin-1 receptor-associated kinase 3 [KO: K04732] [EC: 2.7.11.1] |
| IRAK4; interleukin-1 receptor-associated kinase 4 [KO: K04733] [EC: 2.7.11.1] |
| IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO: K07209] [EC: 2.7.11.10] |
| |
| PSEN1; presenilin 1 [KO: K04505] [EC:3.4.23.-] |
| PSEN2; presenilin 2 (Alzheimer disease 4) [KO: K04522] [EC:3.4.23.-] |
| |